Long-term subcutaneous administration of apomorphine or insulin for Parkinson's disease or diabetes and skin event rates

被引：0

作者：

Wells, K. ^{[5
]}

Zhou, S. ^{[1
]}

Engelhard, J. ^{[6
]}

Oleske, D. ^{[2
]}

Werner, B. ^{[3
]}

Facheris, M. ^{[2
]}

Zamudio, J. ^{[4
]}

机构：

[1] IQVIA, Fairfax, VA USA

[2] Global Epidemiol, N Chicago, IL USA

[3] Team Gesundheit GmbH, Essen, Germany

[4] AbbVie, Mettawa, IL USA

[5] MedSci, Durham, NC USA

[6] IQVIA, Frankfurt, Germany

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPO-121

引用

页码：515 / 515

页数：1

共 50 条

[1] The long-term effect of continuous subcutaneous apomorphine infusions on camptocormia in Parkinson's disease
Mensikova, Katerina
Kaiserova, Michaela
Vastik, Miroslav
Nevrly, Martin
Kurcova, Sandra
Kanovsky, Petr
Colosimo, Carlo
PARKINSONISM & RELATED DISORDERS, 2020, 75 : 14 - 16
[2] Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
Stocchi, F
Vacca, L
De Pandis, MF
Barbato, L
Valente, M
Ruggieri, S
NEUROLOGICAL SCIENCES, 2001, 22 (01) : 93 - 94
[3] Subcutaneous apomorphine injections for advanced Parkinson's disease: a long-term follow-up
Athanasopoulos, D.
Tagaris, G. A.
Karageorgiou, C. E.
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 655 - 655
[4] Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results
F. Stocchi
L. Vacca
M. F. De Pandis
L. Barbato
M. Valente
S. Ruggieri
Neurological Sciences, 2001, 22 : 93 - 94
[5] Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up
Pietz, K
Hagell, P
Odin, P
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (05): : 709 - 716
[6] Continued effect of intermittent subcutaneous apomorphine following long-term use in patients with advanced Parkinson's disease
Pfeiffer, DF
MOVEMENT DISORDERS, 2004, 19 : S281 - S282
[7] Subcutaneous apomorphine in Parkinson's disease
Chaudhuri, KR
Clough, C
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7132): : 641 - 641
[8] Long term use of apomorphine in Parkinson's disease
Tagaris, G.
Sakkou, V.
Alexoudi, A.
Logiotatos, N.
Karageorgiou, C.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S112 - S112
[9] Long-term data on subcutaneous apomorphine in Parkinson's disease patients; a retrospective analysis of a Dutch cohort of 139 patients
Borgemeester, R. W. K.
Drent, M.
Laar, T. V.
MOVEMENT DISORDERS, 2014, 29 : S136 - S136
[10] Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
Garcia Ruiz, Pedro J.
Ignacio, Angel Sesar
Ares Pensado, Begona
Castro Garcia, Alfonso
Alonso Frech, Fernando
Alvarez Lopez, Mercedes
Arbelo Gonzalez, Jose
Baiges Octavio, Joan
Burguera Hernandez, Juan Andrs
Calopa Garriga, Matilde
Campos Blanco, Dulce
Castano Garcia, Belen
Carballo Cordero, Manuel
Chacon Pena, Jose
Espino Ibanez, Anna
Onisalde, Aranzazu Gorospe
Gimenez-Roldan, Santiago
Ibanez, Pilar Granes
Hernandez Vara, Jorge
Ibanez Alonso, Ramon
Jimenez Jimenez, Felix Javier
Krupinski, Jerzy
Kulisevsky Bojarsky, Jaime
Legarda Ramirez, Ines
Lezcano Garcia, Elena
Carlos Martinez-Castrillo, Juan
Mateo Gonzalez, Dolores
Miquel Rodriguez, Francesc
Mir Rivera, Pablo
Munoz Fargas, Elena
Olive Plana, Jose
Obeso Inchausti, Jose
Olivares Romero, Jesus
Olive Plana, Jose
Otermin Vallejo, Pilar
Pascual Sedano, Berta
de Colosia Rama, Victor Perez
Perez Lopez-Fraile, Isabel
Planas Comes, Albert
Puente Periz, Victor
Rodriguez Oroz, Maria Cruz
Sevillano Garcia, Dolores
Solis Perez, Pilar
Suarez Munoz, Jose
Vaamonde Gamo, Julia
Valero Merino, Caridad
Valldeoriola Serra, Francesc
Velazquez Perez, Jose Miguel
Yanez Bana, Rosa
Zamarbide Capdepon, Ivana
MOVEMENT DISORDERS, 2008, 23 (08) : 1130 - 1136

← 1 2 3 4 5 →